The management of urinary incontinence (UI) in older adults requires careful consideration of evidence that supports treatment. This session discusses promising new modalities in the treatment for older adults, including neuromodulation. First-line treatment strategies are presented, along with an in-depth review of current and future pharmacologic options. For patients with UI and excessive moisture skin damage, new evidence-based guidelines of UI-associated skin damage are reviewed. Other potential skin damage differential diagnoses with treatment guidelines are also provided.
Contact hours available until 10/3/2017.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Faculty and Planners Conflict of Interest Disclosure: Faculty and planners have no disclosures to declare.
Speaker: Cathy Reimanis discloses that she receives other financial/material support from Welmedix, Product Advisory Committee.
There are no other disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: This educational activity has been co-provided by Anthony J. Jannetti, Inc. and GAPNA.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, provider number, CEP 5387.
Objectives: 1. Discuss first-line treatments for urinary incontinence. 2. Define second- and third-line treatments for urinary incontinence, including a pharmacological approach and neuromodulation. 3. Develop a plan to prevent and treat skin damage related to incontinence.